Evidence map›Paper›PMID 37504815›Full record

ArticleJournal of imaging2023

VGG16 Feature Extractor with Extreme Gradient Boost Classifier for Pancreas Cancer Prediction.

Wilson Bakasa, Serestina Viriri

Abstract read
In one paragraph

Article in Journal of imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction-a comprehensive review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wilson BakasaSchool of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0003-0927-1301
Serestina ViririSchool of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0002-2850-8645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is greatly improved by an early and accurate diagnosis. Several studies have created automated methods to forecast PDAC development utilising various medical imaging modalities. These papers give a general overview of the classification, segmentation, or grading of many cancer types utilising conventional machine learning techniques and hand-engineered characteristics, including pancreatic cancer. This study uses cutting-edge deep learning techniques to identify PDAC utilising computerised tomography (CT) medical imaging modalities. This work suggests that the hybrid model VGG16-XGBoost (VGG16-backbone feature extractor and Extreme Gradient Boosting-classifier) for PDAC images. According to studies, the proposed hybrid model performs better, obtaining an accuracy of 0.97 and a weighted F1 score of 0.97 for the dataset under study. The experimental validation of the VGG16-XGBoost model uses the Cancer Imaging Archive (TCIA) public access dataset, which has pancreas CT images. The results of this study can be extremely helpful for PDAC diagnosis from computerised tomography (CT) pancreas images, categorising them into five different tumours (T), node (N), and metastases (M) (TNM) staging system class labels, which are T0, T1, T2, T3, and T4.

Indexed as

classificationcomputerised tomographyfeature extractionVGG16XGBoost

Identifiers

PMID37504815
PMCPMC10381878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.